Frank Harder
Keine laufenden Positionen mehr
Karriereverlauf von Frank Harder
Ehemalige bekannte Positionen von Frank Harder
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOPORTO A/S | Finanzdirektor/CFO | 26.05.2010 | 01.01.2014 |
| Investor Relations Kontakt | 01.01.2007 | 01.01.2014 | |
| Public Communications Contact | 01.01.2007 | 01.01.2014 | |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Finanzdirektor/CFO | 01.01.2000 | - |
PhaseOneTrials A/S
 PhaseOneTrials A/S Miscellaneous Commercial ServicesCommercial Services PhaseOneTrials A/S is a Danish Contract Research Organization (CRO) that conducts clinical phase I trials and early phase II trials of new drug candidates. Phase I trials include studies in which a new drug is tested for the first time in healthy humans – also known as “First-in-Man” studies. Early phase II studies, or “Proof-of-Concept” studies, include testing a drug in small groups of patients to determine whether the drug has the desired effects on a given disease. | Finanzdirektor/CFO | - | - |
Ausbildung von Frank Harder
| University of Copenhagen | Graduate Degree |
Statistik
International
| Dänemark | 5 |
Operativ
| Director of Finance/CFO | 3 |
| Graduate Degree | 1 |
| Investor Relations Contact | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOPORTO A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Health Technology |
PhaseOneTrials A/S
PhaseOneTrials A/S Miscellaneous Commercial ServicesCommercial Services PhaseOneTrials A/S is a Danish Contract Research Organization (CRO) that conducts clinical phase I trials and early phase II trials of new drug candidates. Phase I trials include studies in which a new drug is tested for the first time in healthy humans – also known as “First-in-Man” studies. Early phase II studies, or “Proof-of-Concept” studies, include testing a drug in small groups of patients to determine whether the drug has the desired effects on a given disease. | Commercial Services |
- Börse
- Insiders
- Frank Harder
- Erfahrung
